Skip to main content

Table 2 Demographic characteristics and history of hospitalization abroad of patients colonized or infected with CRO, Frankfurt/Main, 1.4.2012- 31.03.2013

From: Burden of carbapenem-resistant organisms in the Frankfurt/Main Metropolitan Area in Germany 2012/2013 – first results and experiences after the introduction of legally mandated reporting

 

Total

P. aeruginosa

A. baumannii

K. pneumoniae

E. coli

Enterobacter

Total

243a

153

28

33

13

12

Age (years) (mean)

58.9 ± 20.1

59.5 ± 19.7

53.1 ± 17.2

59.4 ± 19.5

59.2 ± 23.3

58,0 ± 30,7

Age range (years)

0-97

0-97

18-84

0-90

2-91

0-89

Percentage of male patients

66.7

60.1

82.1

81.8

61.5

83.3

Hospitalization abroad during previous 6 months

32 patientsb

N = 10

N = 11

N = 7

N = 2

N = 1

Iran

Egypt

Egypt

Qatar

Sri Lanka

Kuwait

Brasil

Greece

India

 

Brasil

Ukraine

Nicaragua

  

Qatar

Qatar

Italy

  

India

Kosovo

India (n = 2)

  

Egypt

Russia

Turkey

  

Nicaragua

India

   

Venezuela

Thailand

   

Russia

(n = 2)

   

Macedonia

Turkey

   
 

Morocco

   

Place of residence abroad

N = 21 (8.6%)

N = 11

N = 6

N = 2

N = 2

 

Egypt

Algeria

Egypt

India

 

Iran

Egypt

India

Egypt

 

India

Qatar

   

Kuwait

Kuwait

   

Macedonia

Russia (n = 2)

   

Qatar (n = 2)

    

Russia

    

Saudi Arabia

    

Ukraine

    

Venezuela

    

Infection (%)

29.7

24.2

28.6

30.3

23.1

50.0

Carbapenemase (cases)

32 casesc

Metallo-ß-lactamase, unspecified (n = 3)

OXA-23-like (n = 7)

OXA-23-like (n = 1)

OXA-48 (n = 4)

 

VIM-1 (n = 1)

NDM-1 (n = 1)

OXA-48 (n = 4)

NDM-7 (n = 1)

 

VIM-2 (n = 3)

 

NDM, not further specified (n = 3)

  
  

KPC-2 (n = 1)

  
  

KPC-3 (n = 1)

  
  1. aincluding C. koseri, E. sakazakii. 1 K. oxytoca, P mirabilis.
  2. bincluding 1 patient, C. koseri Libya.
  3. cincluding OXA-48 (n = 1) from C. koseri; NDM1/6 (n = 1) from K. oxytoca.